Nitin Rustogi

R&D, AstraZeneca
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

RNA encoded peptide barcodes enable efficient in vivo screening of RNA delivery systems.

RNA encoded peptide barcodes enable efficient in vivo screening of RNA delivery systems.

Journal: Nucleic acids research
Published: March 04, 2024

Metabolomic Biomarker Signatures for Bipolar and Unipolar Depression.

Metabolomic Biomarker Signatures for Bipolar and Unipolar Depression.

Journal: JAMA psychiatry
Published: October 25, 2023

Exploring peripheral biomarkers of response to simvastatin supplementation in schizophrenia.

Exploring peripheral biomarkers of response to simvastatin supplementation in schizophrenia.

Journal: Schizophrenia research
Published: January 25, 2023

Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers.

Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers.

Journal: Translational psychiatry
Published: April 04, 2022

Peripheral lymphocyte signaling pathway deficiencies predict treatment response in first-onset drug-naïve schizophrenia.

Peripheral lymphocyte signaling pathway deficiencies predict treatment response in first-onset drug-naïve schizophrenia.

Journal: Brain, behavior, and immunity
Published: October 09, 2021

A machine learning algorithm to differentiate bipolar disorder from major depressive disorder using an online mental health questionnaire and blood biomarker data.

A machine learning algorithm to differentiate bipolar disorder from major depressive disorder using an online mental health questionnaire and blood biomarker data.

Journal: Translational psychiatry
Published: August 19, 2020

Diagnostic prediction model development using data from dried blood spot proteomics and a digital mental health assessment to identify major depressive disorder among individuals presenting with low mood.

Diagnostic prediction model development using data from dried blood spot proteomics and a digital mental health assessment to identify major depressive disorder among individuals presenting with low mood.

Journal: Brain, behavior, and immunity
Published: May 28, 2020

A Combined Digital and Biomarker Diagnostic Aid for Mood Disorders (the Delta Trial): Protocol for an Observational Study.

A Combined Digital and Biomarker Diagnostic Aid for Mood Disorders (the Delta Trial): Protocol for an Observational Study.

Journal: JMIR research protocols
Published: February 28, 2020

Antisense oligonucleotide activity in tumour cells is influenced by intracellular LBPA distribution and extracellular vesicle recycling.

Antisense oligonucleotide activity in tumour cells is influenced by intracellular LBPA distribution and extracellular vesicle recycling.

Journal: Communications biology
Published: October 01, 2019

Integrating proteomic, sociodemographic and clinical data to predict future depression diagnosis in subthreshold symptomatic individuals.

Integrating proteomic, sociodemographic and clinical data to predict future depression diagnosis in subthreshold symptomatic individuals.

Journal: Translational psychiatry
Published: August 13, 2019

Multimodel inference for biomarker development: an application to schizophrenia.

Multimodel inference for biomarker development: an application to schizophrenia.

Journal: Translational psychiatry
Published: September 12, 2018

Drug discovery for psychiatric disorders using high-content single-cell screening of signaling network responses ex vivo.

Drug discovery for psychiatric disorders using high-content single-cell screening of signaling network responses ex vivo.

Journal: Science advances
Published: July 27, 2018
Showing 1-12 of 21

Last Updated: 09/26/2026